The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 10 of 45
Back to Result List

Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients

  • Background: Number of positive prostate biopsy cores represents a key determinant between high versus very high-risk prostate cancer (PCa). We performed a critical appraisal of the association between the number of positive prostate biopsy cores and CSM in high versus very high-risk PCa. Methods: Within Surveillance, Epidemiology, and End Results database (2010–2016), 13,836 high versus 20,359 very high-risk PCa patients were identified. Discrimination according to 11 different positive prostate biopsy core cut-offs (≥2–≥12) were tested in Kaplan–Meier, cumulative incidence, and multivariable Cox and competing risks regression models. Results: Among 11 tested positive prostate biopsy core cut-offs, more than or equal to 8 (high-risk vs. very high-risk: n = 18,986 vs. n = 15,209, median prostate-specific antigen [PSA]: 10.6 vs. 16.8 ng/ml, <.001) yielded optimal discrimination and was closely followed by the established more than or equal to 5 cut-off (high-risk vs. very high-risk: n = 13,836 vs. n = 20,359, median PSA: 16.5 vs. 11.1 ng/ml, p < .001). Stratification according to more than or equal to 8 positive prostate biopsy cores resulted in CSM rates of 4.1 versus 14.2% (delta: 10.1%, multivariable hazard ratio: 2.2, p < .001) and stratification according to more than or equal to 5 positive prostate biopsy cores with CSM rates of 3.7 versus 11.9% (delta: 8.2%, multivariable hazard ratio: 2.0, p < .001) in respectively high versus very high-risk PCa. Conclusions: The more than or equal to 8 positive prostate biopsy cores cutoff yielded optimal results. It was very closely followed by more than or equal to 5 positive prostate biopsy cores. In consequence, virtually the same endorsement may be made for either cutoff. However, more than or equal to 5 positive prostate biopsy cores cutoff, based on its existing wide implementation, might represent the optimal choice.
Metadaten
Author:Mike WenzelORCiDGND, Christoph WürnschimmelORCiDGND, Francesco ChierigoORCiD, Zhe Tian, Shahrokh F. ShariatORCiDGND, Carlo TerroneORCiDGND, Fred SaadORCiDGND, Derya TilkiORCiDGND, Markus GraefenORCiDGND, Frederik RoosGND, Luis KluthORCiDGND, Philipp MandelORCiDGND, Chun Felix, Pierre I. Karakiewicz
URN:urn:nbn:de:hebis:30:3-639377
DOI:https://doi.org/10.1002/pros.24202
ISSN:1097-0045
Parent Title (English):The prostate
Publisher:Wiley-Liss
Place of publication:New York, NY
Document Type:Article
Language:English
Date of Publication (online):2021/07/26
Date of first Publication:2021/07/26
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2022/03/22
Tag:NCCN; biopsy cores; high risk; prostate cancer; very high risk
Volume:81
Issue:14
Page Number:9
First Page:1055
Last Page:1063
HeBIS-PPN:493746021
Institutes:Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (English):License LogoCreative Commons - Namensnennung-Nicht kommerziell 4.0